Aspirin for secondary prevention of cardiovascular disease
Author:
Publisher
Elsevier BV
Subject
General Medicine
Reference9 articles.
1. Collaborative meta-analysis of randomised trials of antiplatelet therapy for prevention of death, myocardial infarction, and stroke in high risk patients;BMJ,2002
2. Aspirin in the primary and secondary prevention of vascular disease: collaborative meta-analysis of individual participant data from randomised trials;Baigent;Lancet,2009
3. Association of aspirin use for primary prevention with cardiovascular events and bleeding events: a systematic review and meta-analysis;Zheng;JAMA,2019
4. Monotherapy with a P2Y12 inhibitor or aspirin for secondary prevention in patients with established atherosclerosis: a systematic review and meta-analysis;Chiarito;Lancet,2020
5. A randomised, blinded, trial of clopidogrel versus aspirin in patients at risk of ischaemic events (CAPRIE);Lancet,1996
Cited by 14 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Clinical Updates in Coronary Artery Disease: A Comprehensive Review;Journal of Clinical Medicine;2024-08-06
2. The association between aspirin use and immune-related adverse events in specific cancer patients receiving ICIs therapy: analysis of the FAERS database;Frontiers in Pharmacology;2023-11-15
3. Lifestyle Approach and Medical Therapy of Lower Extremity Peripheral Artery Disease;The American Journal of Medicine;2023-11
4. Model based on single-nucleotide polymorphism to discriminate aspirin resistance patients;Stroke and Vascular Neurology;2023-08-16
5. Dual Antiplatelet Therapy: A Concise Review for Clinicians;Life;2023-07-18
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3